8.775USD+3.36%Mkt Cap: 913.54M USDP/E: —Last update: 2026-06-01
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms in cancers in the United States. Its clinical stage produ…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap913.54M USD
Enterprise Value598.49M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-129.47M USD
Revenue/Share—
Last Price8.775 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees104
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS68622P1093
Valuation
P/E (Trailing)—
P/E (Forward)-5.45
PEG—
EV/EBITDA-4.02
EV/Revenue—
P/S—
P/B2.10
EPS (TTM)-1.39
EPS (Forward)-1.55
52W Range
7.23020% of range14.93
52W High14.93 USD
52W Low7.230 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-33.68%
ROA-31.66%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-110.97M USD
CapEx (TTM)712.00K USD
FCF Margin—
FCF Yield-7.44%
Net Debt-275.20M USD
Net Debt/EBITDA1.85
Balance Sheet
Debt/Equity0.01
Current Ratio16.33
Quick Ratio15.87
Book Value/Sh4.016 USD
Cash/Share2.724 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)20.36 USD
Target Range15.00 USD – 25.00 USD
# Analysts14
Ownership
Shares Out.103.52M
Float82.53M
Insiders5.85%
Institutions113.77%
Short Interest
Short Ratio15.5d
Short % Float21.42%
Short % Out.21.20%
Shares Short21.94M
Short (prev mo.)20.74M
Technical
SMA 509.749 (-10.0%)
SMA 20010.83 (-19.0%)
Beta1.10
S&P 52W Chg27.94%
Avg Vol (30d)1.30M
Avg Vol (10d)1.29M
Technical Indicators
RSI (14)41.3
MACD-0.4064
MACD Signal-0.4897
MACD Hist.+0.0834
BB Upper9.759 USD
BB Middle8.711 USD
BB Lower7.664 USD
BB Width24.04%
ATR (14)0.5134 USD
Vol Ratio (20d)2.44x